InvestorsHub Logo
Followers 45
Posts 9536
Boards Moderated 0
Alias Born 07/14/2005

Re: Echo20 post# 30591

Wednesday, 04/21/2010 7:55:09 AM

Wednesday, April 21, 2010 7:55:09 AM

Post# of 146240
Echo20,

Thanks for the update,... this whole last part has lots of interesting comments:

I feel that we're at an important juncture in the life of NanoViricides. We now have a number of "lead drug candidates" for an FDA filing(s) and will decide in the next 2-3 months what the submission order will be. The priority voucher program is an important consideration, especially since there are a number of tropical medicine diseases that don't require human trials except for Phase I safety when the drug is given to healthy volunteers. And, there's an immediate financial payoff once approval is obtained. Only a few non human primates are needed for the other Phases which makes the trials go rather quickly.

There is now widespread understanding in the scientific community about the usefulness of nanomedicine and particularly of our nanoparticles, called nanomicelles. You only have to go to http://nano.cancer.gov to see that they're doing the same thing in oncology, targeting and destroying individual cancer cells, as we're doing with viruses.

It's important to look into the future but at the same time make the correct decisions that will help us achieve our long-term goals

I'm most interested in seeing this S3 shelf registration go effective so we can leave this quiet period and update everyone on our most recent studies.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News